Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

As shown in Figure 2 and 3, the pooled SMDs for alogliptin 12.5 mg treated vs controls, and alogliptin 25 mg treated vs controls demonstrated a significant reduction in HbA1c in patients treated ...

"Controlling blood sugar levels is very important in the overall treatment and care of diabetes. Alogliptin helps stimulate the release of insulin after a meal, which leads to better blood sugar ...

Alogliptin is prescribed to reduce high blood sugar level in patients with type 2 diabetes along with diet control and exercise. It should not be used in treating diabetic ketoacidosis or type 1 ...

Alogliptin is prescribed to reduce high blood sugar level in patients with type 2 diabetes along with diet control and exercise. • Caution should be exercised in patients with history of liver ...

If you are already taking both alogliptin and metformin as separate tablets, Nesina Met can replace them in one tablet. Nesina Met is not for patients with type 1 diabetes mellitus or diabetic ...